See more : Lida Resources Inc. (LIDA.CN) Income Statement Analysis – Financial Results
Complete financial analysis of 1Life Healthcare, Inc. (ONEM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 1Life Healthcare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Neelkanth Rockminerals Limited (NEELKAN.BO) Income Statement Analysis – Financial Results
- Gecoss Corporation (GCSSF) Income Statement Analysis – Financial Results
- Champion Technology Holdings Limited (0092.HK) Income Statement Analysis – Financial Results
- QuakeSafe Technologies Co., Ltd. (300767.SZ) Income Statement Analysis – Financial Results
- Yealink Network Technology Co., Ltd. (300628.SZ) Income Statement Analysis – Financial Results
1Life Healthcare, Inc. (ONEM)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.onemedical.com
About 1Life Healthcare, Inc.
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 621.55M | 380.22M | 276.26M | 212.68M | 176.77M |
| Cost of Revenue | 861.16M | 435.18M | 234.96M | 167.62M | 136.18M | 120.71M |
| Gross Profit | 184.39M | 186.37M | 145.26M | 108.64M | 76.50M | 56.06M |
| Gross Profit Ratio | 17.64% | 29.98% | 38.20% | 39.33% | 35.97% | 31.72% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.83M | 323.13M | 157.28M | 108.97M | 85.81M | 57.96M |
| Selling & Marketing | 97.07M | 61.99M | 36.97M | 39.52M | 25.79M | 19.17M |
| SG&A | 512.90M | 385.12M | 194.25M | 148.49M | 111.60M | 77.14M |
| Other Expenses | 91.19M | 44.73M | 22.37M | 14.27M | 9.95M | 10.69M |
| Operating Expenses | 604.08M | 429.85M | 216.62M | 162.75M | 121.54M | 87.82M |
| Cost & Expenses | 1.47B | 865.04M | 451.58M | 330.37M | 257.72M | 208.53M |
| Interest Income | 2.02M | 798.00K | 1.81M | 4.50M | 2.25M | 386.00K |
| Interest Expense | 11.68M | 13.76M | 13.43M | 474.00K | 804.00K | 834.00K |
| Depreciation & Amortization | 91.19M | 46.50M | 22.37M | 24.50M | 9.95M | 10.69M |
| EBITDA | -326.50M | -196.19M | -53.03M | -27.49M | -33.64M | -19.15M |
| EBITDA Ratio | -31.23% | -31.56% | -13.95% | -9.95% | -15.82% | -10.83% |
| Operating Income | -417.68M | -242.69M | -71.36M | -54.11M | -45.05M | -31.76M |
| Operating Income Ratio | -39.95% | -39.05% | -18.77% | -19.59% | -21.18% | -17.97% |
| Total Other Income/Expenses | -11.68M | -13.76M | -18.19M | 505.00K | -430.00K | 198.00K |
| Income Before Tax | -429.36M | -256.44M | -89.54M | -53.61M | -45.48M | -31.56M |
| Income Before Tax Ratio | -41.07% | -41.26% | -23.55% | -19.41% | -21.38% | -17.85% |
| Income Tax Expense | -31.51M | -1.80M | -123.00K | 87.00K | 25.00K | 126.00K |
| Net Income | -397.85M | -254.64M | -88.72M | -52.55M | -44.42M | -30.80M |
| Net Income Ratio | -38.05% | -40.97% | -23.33% | -19.02% | -20.88% | -17.42% |
| EPS | -2.02 | -1.66 | -0.75 | -0.43 | -0.48 | -0.29 |
| EPS Diluted | -2.02 | -1.66 | -0.75 | -0.43 | -0.48 | -0.29 |
| Weighted Avg Shares Out | 197.05M | 153.70M | 118.38M | 122.41M | 91.66M | 104.62M |
| Weighted Avg Shares Out (Dil) | 197.05M | 153.70M | 118.38M | 122.41M | 91.66M | 104.62M |
1Life Healthcare, Inc's. (ONEM) CEO Amir Dan Rubin on Q4 2021 Results - Earnings Call Transcript
1Life Healthcare (One Medical) Announces Date of its Fourth Quarter and Full Year 2021 Results Conference Call
1LifeHealthcare Stock Is Plunging. That Does Not Make It Cheap
New Strong Sell Stocks for January 19th
1Life Healthcare (One Medical) to Announce Future Conference Participation on Investor Relations Website
ARK Genomic ETF: Likely Economic Victim With Low Institutional Interest
1Life Healthcare, Inc. (ONEM) CEO Amir Rubin on Q3 2021 Results - Earnings Call Transcript
1Life Healthcare, Inc. (ONEM) Reports Q3 Loss, Tops Revenue Estimates
Adding RubiconMD Strengthens Oak Street's Value-Based Services
Cigna Adds Iora Primary Care to Medicare Advantage Network in Phoenix Area
Source: https://incomestatements.info
Category: Stock Reports